- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 819-833 of
1,261 results
2480 Exhibit: EX2480 IQVIA, About us, httpswwwiqviacomabout us
Document
IPR2023-00724, No. 2480 Exhibit - EX2480 IQVIA, About us, httpswwwiqviacomabout us (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2523 Exhibit: EX2523 Eli Lilly Co, SEC Form 10 K for the Year Ended December 31...
Document
IPR2023-00724, No. 2523 Exhibit - EX2523 Eli Lilly Co, SEC Form 10 K for the Year Ended December 31, 2022 Feb 22, 2023 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2500 Exhibit: EX2500 Novo Nordisk, Financial report for the period 1 January 2019...
Document
IPR2023-00724, No. 2500 Exhibit - EX2500 Novo Nordisk, Financial report for the period 1 January 2019 to 30 September 2019 Nov 1, 2019 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2093 Exhibit: EX2093 Davies, MJ, et al, Cardiovascular outcomes trials a paradigm...
Document
IPR2023-00724, No. 2093 Exhibit - EX2093 Davies, MJ, et al, Cardiovascular outcomes trials a paradigm shift in the current management of type 2 diabetes, Cardiovasc Diabetol, 21144 2022 (P...
|
|
Cite Document
2088 Exhibit: EX2088 American College of Cardiology, Clinical Topics, Diabetes an...
Document
IPR2023-00724, No. 2088 Exhibit - EX2088 American College of Cardiology, Clinical Topics, Diabetes and Cardiometabolic Disease, httpswwwaccorgClinical TopicsDiabetes and Cardiometabol...
|
|
Cite Document
2424 Exhibit: EX2424 US Food Drug Administration, DrugsFDA, Jentadueto® XR
Document
IPR2023-00724, No. 2424 Exhibit - EX2424 US Food Drug Administration, DrugsFDA, Jentadueto® XR (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2384 Exhibit: EX2384 Clamp, LD, et al, Enhanced insulin sensitivity in successful, l...
Document
IPR2023-00724, No. 2384 Exhibit - EX2384 Clamp, LD, et al, Enhanced insulin sensitivity in successful, long term weight loss maintainers compared with matched controls with no weight loss his...
|
|
Cite Document
2417 Exhibit: EX2417 AstraZeneca, “AstraZeneca and Bristol Myers Squibb compl...
Document
IPR2023-00724, No. 2417 Exhibit - EX2417 AstraZeneca, “AstraZeneca and Bristol Myers Squibb complete expansion of diabetes alliance through Bristol Myers Squibb’s acquisition of Amylin P...
|
|
Cite Document
3002 Exhibit: Exhibit 3002
Document
IPR2023-00724, No. 3002 Exhibit - Exhibit 3002 (P.T.A.B. Nov. 29, 2023)
|
|
Cite Document
1039 Exhibit: Victoza PDR
Document
IPR2023-00724, No. 1039 Exhibit - Victoza PDR (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
1323 Exhibit: Exhibit 1323 Redacted NN OZEM 004426808
Document
IPR2023-00724, No. 1323 Exhibit - Exhibit 1323 Redacted NN OZEM 004426808 (P.T.A.B. Jun. 21, 2024)
|
|
Cite Document
1105 Exhibit: Exhibit 1105 Victoza Orange Book
Document
IPR2023-00724, No. 1105 Exhibit - Exhibit 1105 Victoza Orange Book (P.T.A.B. May. 22, 2024)
|
|
Cite Document
2543 Exhibit: EX2543 Email Exchange Between Counsel for Sun Pharmaceutical In...
Document
IPR2023-00724, No. 2543 Exhibit - EX2543 Email Exchange Between Counsel for Sun Pharmaceutical Indus tries, Ltd and Counsel for Patent Owner Regarding Request to File Stipulation, Sun...
|
|
Cite Document
1157 Exhibit: Exhibit 1157 Davidson
Document
IPR2023-00724, No. 1157 Exhibit - Exhibit 1157 Davidson (P.T.A.B. May. 22, 2024)
|
|
Cite Document
1023 Exhibit: Drucker 2003
Document
IPR2023-00724, No. 1023 Exhibit - Drucker 2003 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
